Aggregating clinical trial data with real-world evidence to improve drug coverage, Rx decisions goo.gl/K5zICV Via @AdveraHealth
Wall Street analysts, pharma reporters should foll…
posted on October 23, 2015 by
Wall Street analysts, pharma reporters should follow drug safety analyses by @AdveraHealth. Ahead of FDA warning on AbbVie Viekira.
Retweeted Advera Health (@AdveraHealth): Viekira…
posted on October 23, 2015 by
Retweeted Advera Health (@AdveraHealth): Viekira Pak has RxCost (medical costs from drug side effects) of $151… fb.me/1OcWOvb39